Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening
Manfred Vogt, M.D., Thomas Lang, M.D., Gert Frösner, M.D., Christiane Klingler, Anna F. Sendl, Ph.D., Anita Zeller, Baldur Wiebecke, M.D., Barbara Langer, M.D., Hans Meisner, M.D., and John Hess, M.D., Ph.D.
Background and Methods There are few data on the prevalenceand clinical outcome of hepatitis C infection in children. Westudied 458 children who underwent cardiac surgery in Munich,Germany, before 1991, when blood-donor screening for hepatitisC was introduced in Germany. Their mean age at first operationwas 2.8 years; none of the children had received blood transfusionsbefore or after cardiac surgery, and none of their mothers hadantibodies to hepatitis C virus (anti-HCV). We compared thesepatients with 458 control subjects matched for age and sex.
Results Sixty-seven (14.6 percent) of the 458 patients who hadundergone cardiac surgery had anti-HCV, as compared with 3 (0.7percent) of the control subjects (P<0.001). At a mean intervalof 19.8 years after the first operation, 37 (55 percent) ofthe 67 patients who were positive for anti-HCV had detectableHCV RNA in their blood. The infection had cleared in the other30 patients, as evidenced by negative results on three polymerase-chain-reactionanalyses performed at six-month intervals. Only 1 of the 37patients who were positive for HCV RNA had elevated levels ofliver enzymes; that patient had severe right-sided congestiveheart failure. Of the 17 patients who underwent liver biopsies,only 3 had histologic signs of progressive liver damage. Thesethree patients had additional risk factors: two had congestiveheart failure, and the third had also been infected with hepatitisB virus.
Conclusions Children who had undergone cardiac surgery in Germanybefore the implementation of blood-donor screening for hepatitisC had a substantial risk of acquiring the infection. However,after about 20 years, the virus had spontaneously cleared inmany patients. The clinical course in those still infected seemsmore benign than would be expected in people infected as adults.
Source Information
From the Departments of Pediatric Cardiology and Cardiac Surgery, German Heart Center, Technical University of Munich (M.V., H.M., J.H.); the Children's University Hospital (T.L., A.F.S.) and the Institute of Pathology (B.W.), Ludwig Maximilians University; and the Max von Pettenkofer Institute (G.F., C.K., A.Z., B.L.) all in Munich, Germany. Presented in part at the Annual Meeting of the German Society of Pediatric Gastroenterology and Nutrition, Kloster Irsee, Germany, May 1517, 1997; at the Annual Meeting of the European and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition, Toulouse, France, May 2730, 1998; at the Annual Meeting of the American Association of the Study of Liver Disease, Chicago, November 610, 1998; and at the Annual Meeting of the European Association of Pediatric Cardiology, Dublin, Ireland, June 1013, 1998.
Address reprint requests to Dr. Lang at the Children's University Hospital, Pediatric Gastroenterology, Lindwurmstr. 4, D-80337 Munich, Germany, or at thomas.lang{at}kk-i.med.uni-muenchen.de.
Hepatitis C in Children
Birnbaum A. H., Shneider B. L., Moy L., Lang T., Hess J., Vogt M., Jonas M. M.
Extract |
Full Text
N Engl J Med 2000;
342:290-292, Jan 27, 2000.
Correspondence
This article has been cited by other articles:
Di Marco, V., Capra, M., Gagliardotto, F., Borsellino, Z., Cabibi, D., Barbaria, F., Ferraro, D., Cuccia, L., Ruffo, G. B., Bronte, F., Di Stefano, R., Almasio, P. L., Craxi, A.
(2008). Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. haematol
93: 1243-1246
[Abstract][Full Text]
Davison, S M, Mieli-Vergani, G, Sira, J, Kelly, D A
(2006). Perinatal hepatitis C virus infection: diagnosis and management.. Arch. Dis. Child.
91: 781-785
[Abstract][Full Text]
Bakr, I, Rekacewicz, C, El Hosseiny, M, Ismail, S, El Daly, M, El-Kafrawy, S, Esmat, G, Hamid, M A, Mohamed, M K, Fontanet, A
(2006). Higher clearance of hepatitis C virus infection in females compared with males. Gut
55: 1183-1187
[Abstract][Full Text]
Kelly, D.
(2006). Viral hepatitis B and C in children. JRSM
99: 353-357
[Full Text]
Farci, P., Quinti, I., Farci, S., Alter, H. J., Strazzera, R., Palomba, E., Coiana, A., Cao, D., Casadei, A. M., Ledda, R., Iorio, R., Vegnente, A., Diaz, G., Tovo, P.-A.
(2006). Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc. Natl. Acad. Sci. USA
103: 8475-8480
[Abstract][Full Text]
Zhang, M., Rosenberg, P. S., Brown, D. L., Preiss, L., Konkle, B. A., Eyster, M. E., Goedert, J. J., for the Second Multicenter Hemophilia Cohort Study,
(2006). Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood
107: 892-897
[Abstract][Full Text]
Anand, B S, Thornby, J
(2005). Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut
54: 1468-1472
[Abstract][Full Text]
Bortolotti, F, Resti, M, Marcellini, M, Giacchino, R, Verucchi, G, Nebbia, G, Zancan, L, Marazzi, M G, Barbera, C, Maccabruni, A, Zuin, G, Maggiore, G, Balli, F, Vajro, P, Lepore, L, Molesini, M, Guido, M, Bartolacci, S, Noventa, F, the Italian Observatory for Hepatitis C in childre,
(2005). Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome. Gut
54: 852-857
[Abstract][Full Text]
Canobio, S., Guilbert, C. M., Troesch, M., Samson, J., Lemay, M., Pelletier, V. A., Bernard-Bonnin, A.-C., Kozielski, R., Lapointe, N., Martin, S. R., Soudeyns, H.
(2004). Differing Patterns of Liver Disease Progression and Hepatitis C Virus (HCV) Quasispecies Evolution in Children Vertically Coinfected with HCV and Human Immunodeficiency Virus Type 1. J. Clin. Microbiol.
42: 4365-4369
[Abstract][Full Text]
Castellino, S., Lensing, S., Riely, C., Rai, S. N., Davila, R., Hayden, R. T., Fleckenstein, J., Levstik, M., Taylor, S., Dean, P. J., Kippenbrock, S., Pope, J., Carr, J., Strickland, D. K., Hudson, M. M.
(2004). The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort. Blood
103: 2460-2466
[Abstract][Full Text]
Cividini, A., Cerino, A., Muzzi, A., Furione, M., Rebucci, C., Segagni, L., Gatti, M., Barnaba, V., Mondelli, M. U.
(2003). Kinetics and Significance of Serum Hepatitis C Virus Core Antigen in Patients with Acute Hepatitis C. J. Clin. Microbiol.
41: 2144-2146
[Abstract][Full Text]
Oliver, W. C. Jr, Beynen, F. M., Nuttall, G. A., Schroeder, D. R., Ereth, M. H., Dearani, J. A., Puga, F. J.
(2003). Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann. Thorac. Surg.
75: 1506-1512
[Abstract][Full Text]
Angelucci, E., Muretto, P., Nicolucci, A., Baronciani, D., Erer, B., Gaziev, J., Ripalti, M., Sodani, P., Tomassoni, S., Visani, G., Lucarelli, G.
(2002). Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood
100: 17-21
[Abstract][Full Text]
Minola, E., Prati, D., Suter, F., Maggiolo, F., Caprioli, F., Sonzogni, A., Fraquelli, M., Paggi, S., Conte, D.
(2002). Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood
99: 4588-4591
[Abstract][Full Text]
Hoofnagle, J. H.
(2001). Therapy for Acute Hepatitis C. NEJM
345: 1495-1497
[Full Text]
Hadzic, N
(2001). Hepatitis C in pregnancy. Arch. Dis. Child. Fetal Neonatal Ed.
84: 201F-204
[Full Text]
Yee, T T, Griffioen, A, Sabin, C A, Dusheiko, G, Lee, C A
(2000). The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut
47: 845-851
[Abstract][Full Text]
Lackner, H., Moser, A., Deutsch, J., Kessler, H. H., Benesch, M., Kerbl, R., Schwinger, W., Dornbusch, H.-J., Preisegger, K.-H., Urban, C.
(2000). Interferon-alpha and Ribavirin in Treating Children and Young Adults With Chronic Hepatitis C After Malignancy. Pediatrics
106: 53e-53
[Abstract][Full Text]
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., Laeyendecker, O., Boitnott, J., Wilson, L. E., Vlahov, D.
(2000). The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. JAMA
284: 450-456
[Abstract][Full Text]
Strickland, D. K., Riely, C. A., Patrick, C. C., Jones-Wallace, D., Boyett, J. M., Waters, B., Fleckenstein, J. F., Dean, P. J., Davila, R., Caver, T. E., Hudson, M. M.
(2000). Hepatitis C infection among survivors of childhood cancer. Blood
95: 3065-3070
[Abstract][Full Text]
Aach, R. D., Yomtovian, R. A., Hack, M.
(2000). Neonatal and Pediatric Posttransfusion Hepatitis C: A Look Back and a Look Forward. Pediatrics
105: 836-842
[Full Text]
Birnbaum, A. H., Shneider, B. L., Moy, L., Lang, T., Hess, J., Vogt, M., Jonas, M. M.
(2000). Hepatitis C in Children. NEJM
342: 290-292
[Full Text]
Jonas, M. M.
(1999). Hepatitis C Infection in Children. NEJM
341: 911-913
[Full Text]
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., Manns, M. P., the German Acute Hepatitis C Therapy Group,
(2001). Treatment of Acute Hepatitis C with Interferon Alfa-2b. NEJM
345: 1452-1457
[Abstract][Full Text]